We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vivione Biosciences, Inc. | TSXV:PIA | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
PACEpartners Inc. (TSX VENTURE:PIA) (the "Corporation") - Further to the Corporation's press release dated April 29, 2013 which announced the terms of settlement of debt between the Corporation and two insiders, the Corporation reports that it has issued an aggregate of 169,538 Class A Common Shares of the Corporation to the two insiders, as described in the referenced press release above, and that the debt is fully extinguished. Cautionary Statements The securities mentioned herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This press release does not constitute an offer to sell or the solicitation of any offer to buy these securities in any jurisdiction. FOR FURTHER INFORMATION PLEASE CONTACT: PACEpartners Inc. Kevin Kuykendall Chief Executive Officer (214) 886-5733
1 Year Vivione Biosciences, Inc. Chart |
1 Month Vivione Biosciences, Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions